← Leaderboards
Farren J. Isaacs
Yale University
$3,853,171
Attributed
$7,193,380
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,193,380 · 3
By mechanism
R01$7,193,380 · 3
Top collaborators
- Jesse Rinehart18 shared
Most similar at Yale University
Same institution · by research overlap
- Jesse Rinehart$5,829,268
- Dieter G Soll$29,619,061
- Lloyd G Cantley$26,240,423
- Rong Fan$22,943,481
- Gerald I Shulman$43,949,903
Others in their field
Top investigators on “Phosphoserine”
- Dieter G Soll · Yale University$10,723,671
- Michael B Yaffe · Massachusetts Institute Of Technology$10,586,421
- Jesse Rinehart · Yale University$5,057,608
- Einar M Sigurdsson · New York University School Of Medicine$4,404,180
- George M Shaw · University Of Pennsylvania$3,751,481
- Raiees Ahmad Andrabi · Scripps Research Institute, The$3,751,481
Research focus
PhosphoserineEscherichia ColiCellsProteinsPhosphoproteinsRecombinantsSiteTechnologyPhosphorylationTranslationsSignal TransductionPost-Translational Protein ProcessingHuman DiseaseNovel TherapeuticsAmino AcidsTerminator CodonPhysiologicalGenomicsRegulationNew Therapeutic TargetProteomeOrganismSpecificityMolecular
Grant awards (19)
Engineering a recoded organism to discover PTM-mediated protein binders$512,961
R01 · FY2025 · GM · contact PI
Deciphering human signaling networks through synthetic activation of proteins in genomically recoded organisms with multiple open codons$346,679
R01 · FY2024 · GM
Developing next-generation genomically recoded organisms to synthetically activate biomarkers for drug discovery$499,765
R01 · FY2023 · GM · contact PI
Deciphering human signaling networks through synthetic activation of proteins in genomically recoded organisms with multiple open codons$346,679
R01 · FY2023 · GM
Developing next-generation genomically recoded organisms to synthetically activate biomarkers for drug discovery$575,867
R01 · FY2022 · GM · contact PI
Deciphering human signaling networks through synthetic activation of proteins in genomically recoded organisms with multiple open codons$360,577
R01 · FY2022 · GM
Developing next-generation genomically recoded organisms to synthetically activate biomarkers for drug discovery$583,364
R01 · FY2021 · GM · contact PI
Deciphering human signaling networks through synthetic activation of proteins in genomically recoded organisms with multiple open codons$358,249
R01 · FY2021 · GM
Expanding the genetic code with phosphotyrosine and phosphothreonine$310,103
R01 · FY2021 · GM · contact PI
Developing next-generation genomically recoded organisms to synthetically activate biomarkers for drug discovery$588,033
R01 · FY2020 · GM · contact PI
Expanding the genetic code with phosphotyrosine and phosphothreonine$310,634
R01 · FY2020 · GM · contact PI
Revealing substrates and phosphoproteome level function of human STE20 kinases$117,717
R01 · FY2020 · GM
Revealing substrates and phosphoproteome level function of human STE20 kinases$335,000
R01 · FY2019 · GM
Expanding the genetic code with phosphotyrosine and phosphothreonine$311,142
R01 · FY2019 · GM · contact PI
Revealing substrates and phosphoproteome level function of human STE20 kinases$335,000
R01 · FY2018 · GM
Expanding the genetic code with phosphotyrosine and phosphothreonine$304,820
R01 · FY2018 · GM · contact PI
Revealing substrates and phosphoproteome level function of human STE20 kinases$335,000
R01 · FY2017 · GM
Revealing substrates and phosphoproteome level function of human STE20 kinases$335,000
R01 · FY2016 · GM
Revealing substrates and phosphoproteome level function of human STE20 kinases$326,790
R01 · FY2015 · GM